BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9033415)

  • 1. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
    Lexchin J
    CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
    Desjardins JG
    CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian marketing codes: how well are they controlling pharmaceutical promotion?
    Lexchin J
    Int J Health Serv; 1994; 24(1):91-104. PubMed ID: 8150569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A; Davis C; Mulinari S
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voluntary self-regulatory codes: what should we expect?
    Lexchin J
    Am J Bioeth; 2003; 3(3):49-50. PubMed ID: 14594491
    [No Abstract]   [Full Text] [Related]  

  • 6. Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.
    Zetterqvist AV; Merlo J; Mulinari S
    PLoS Med; 2015 Feb; 12(2):e1001785. PubMed ID: 25689460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada.
    Lexchin J
    Int J Soc Determinants Health Health Serv; 2023 Oct; 53(4):518-527. PubMed ID: 36938584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation.
    Herxheimer A; Collier J
    BMJ; 1990 Feb; 300(6720):307-11. PubMed ID: 2106963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
    Czerw A; Marek EM
    Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug industry's new code criticised for lacking teeth.
    Coombes R
    BMJ; 2005 Nov; 331(7527):1225. PubMed ID: 16308367
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
    Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical promotion in Canada: convince them or confuse them.
    Lexchin J
    Int J Health Serv; 1987; 17(1):77-89. PubMed ID: 3557776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019.
    Zagrodney KAP; Sheikhan NY; Pinto A; Sheikhan T; Witek TJ
    Pharmaceut Med; 2021 Jan; 35(1):31-38. PubMed ID: 33453042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lundbeck broke advertising rules.
    Dyer O
    BMJ; 2003 May; 326(7397):1004. PubMed ID: 12742919
    [No Abstract]   [Full Text] [Related]  

  • 16. Can drug companies have it both ways?
    Rapp MS
    CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug companies' evidence to justify advertising.
    Wade VA; Mansfield PR; McDonald PJ
    Lancet; 1989 Nov; 2(8674):1261-3. PubMed ID: 2573769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?
    Roughead EE; Gilbert AL; Harvey KJ
    Int J Health Serv; 1998; 28(2):269-79. PubMed ID: 9595344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complaints about advertising of medicines are encouraged.
    Simmonds H
    BMJ; 2002 Apr; 324(7341):850-1. PubMed ID: 11934787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.